摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[(E)-(1-methyl-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)methyl]benzoic acid | 5809-84-7

中文名称
——
中文别名
——
英文名称
4-[(E)-(1-methyl-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)methyl]benzoic acid
英文别名
4-[(E)-(1-methyl-2,4,6-trioxo-1,3-diazinan-5-ylidene)methyl]benzoic acid
4-[(E)-(1-methyl-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)methyl]benzoic acid化学式
CAS
5809-84-7
化学式
C13H10N2O5
mdl
——
分子量
274.23
InChiKey
FOCATHRHRUAECA-RMKNXTFCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    104
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • METHODS AND COMPOSITIONS FOR TARGETING C-REL
    申请人:Cornell Research Foundation, Inc.
    公开号:EP2010225A2
    公开(公告)日:2009-01-07
  • Methods and Compositions for Targeting c-Rel
    申请人:Liou Hsiou-chi
    公开号:US20100055116A1
    公开(公告)日:2010-03-04
    The present invention relates to compositions and methods for targeting c-Rel. In particular, the present invention provides compositions and methods for treating cancers, inflammatory diseases, autoimmune diseases, and transplant rejection by inhibiting c-Rel activity and for regulating c-Rel for research and drug screening applications.
  • [EN] METHODS AND COMPOSITIONS FOR TARGETING C-REL<br/>[FR] PROCEDES ET COMPOSITIONS DESTINES A CIBLER LE C-REL
    申请人:CORNELL RES FOUNDATION INC
    公开号:WO2007120842A2
    公开(公告)日:2007-10-25
    [EN] The present invention relates to compositions and methods for targeting c-Rel. In particular, the present invention provides compositions and methods for treating cancers, inflammatory diseases, autoimmune diseases, and transplant rejection by inhibiting c-Rel activity and for regulating c-Rel for research and drug screening applications.
    [FR] La présente invention concerne des compositions et des procédés destinés à cibler le c-Rel. L'invention porte en particulier sur des compositions et des procédés permettant de traiter les cancers, les maladies inflammatoires, les maladies auto-immunes et les rejets de greffe en inhibant l'activité c-Rel, et de réguler le c-Rel dans le cadre d'applications de recherche et de criblage de nouveaux médicaments.
查看更多